# The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients

> **NCT02648659** · PHASE4 · COMPLETED · sponsor: **Kyungpook National University Hospital** · enrollment: 50 (actual)

## Conditions studied

- Peptic Ulcer

## Interventions

- **DRUG:** Ilaprazole
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT02648659
- **Lead sponsor:** Kyungpook National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-02
- **Primary completion:** 2017-01-06
- **Final completion:** 2017-02-14
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648659, "The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02648659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*